Mark Schoenberg Uro Gen Pharma Ltd. (URGN) insider trading activity
Mark Schoenberg is Chief Medical Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 139,025 shares of URGN, which is worth approximately $3.38 Million. The most recent transaction as insider was on Oct 26, 2020, when has been sold 208 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
139K
6.71%
3M change
4.18%
12M change
Total Value Held
$3.38 Million
MS
Mark Schoenberg
Chief Medical Officer
Princeton, NJ